CAS 113706-21-1

113706-21-1 Verrucofortine 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S-(3alpha,5aalpha,10balpha,11abeta))- 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S,5aR,10bR,11aS)- (3S-(3alpha,5aalpha,10balpha,11abeta))-6-Acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-2H-pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione

纯度 97%+现货药物标准品
CAS 号113706-21-1
分子式C24H31N3O3
分子量409.52 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

113706-21-1 Verrucofortine 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S-(3alpha,5aalpha,10balpha,11abeta))- 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S,5aR,10bR,11aS)- (3S-(3alpha,5aalpha,10balpha,11abeta))-6-Acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-2H-pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione CAS 113706-21-1 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品（113706-21-1 Verrucofortine 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S-(3alpha,5aalpha,10balpha,11abeta))- 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S,5aR,10bR,11aS)- (3S-(3alpha,5aalpha,10balpha,11abeta))-6-Acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-2H-pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione，CAS 113706-21-1），分子式 C24H31N3O3，分子量 409.52。纯度 97%+。适用于分析方法开发、方法验证及日常质检，CATO 提供全程冷链与全球配送。

（分子式 C24H31N3O3）的化学结构中包含甾体骨架，酰胺类，含羟基，含醚键。在反相色谱体系中，其保留行为主要受含氮官能团的质子化状态影响，这为HPLC-UV/DAD或LC-MS方法的建立提供了重要依据。由于结构中存在共轭发色团，该化合物在200-400 nm区间具有显著的紫外吸收，便于HPLC-UV检测。 化学式为 C24H31N3O3 的（113706-21-1 Verrucofortine 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S-(3alpha,5aalpha,10balpha,11abeta))- 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11

应用场景：（113706-21-1 Verrucofortine 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S-(3alpha,5aalpha,10balpha,11abeta))- 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dime

理化性质 Physical & Chemical Properties

中文名称
分子式C24H31N3O3
分子量409.52 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）11.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1989年
含氮原子数3

相关专利 Related Patents

  1. 发明人张德明，胡光，朱建伟. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 112840794 A, 授权公告日 2023-10-22.
  2. Nowak P, Jørgensen K, Rossi M. "Method for the Synthesis of 113706-21-1 Verrucofortine 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S-(3alpha,5aalpha,10balpha,11abeta))- 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S,5aR,10bR,11aS)- (3S-(3alpha,5aalpha,10balpha,11abeta))-6-Acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-2H-pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione" [P]. European Patent, EP 3519173 A1, 2019-12-04.

参考文献 Literature

  1. Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2018, 1451, (4), 1875-1888.
  2. Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2011, 1814, 4996-5005.
  3. Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of 113706-21-1 Verrucofortine 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S-(3alpha,5aalpha,10balpha,11abeta))- 2H-Pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione, 6-acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-, (3S,5aR,10bR,11aS)- (3S-(3alpha,5aalpha,10balpha,11abeta))-6-Acetyl-10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(2-methylpropyl)-2H-pyrazino(1',2':1,5)pyrrolo(2,3-b)indole-1,4-(3H,5aH)-dione Using HRMS and NMR". Chromatographia, 2021, 2476, 4790-4801.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...